Saturday, July 11, 2026

pharma · Ischemic Stroke · Spinal Cord Injury

Neuroscience Trials Australia

Neuroscience Trials Australia clinical programs — 3 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Parkville, AU HQ
14 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Parkville, AU
Employees
14
Programs
5
Drugs
9
Patents
0
Intelligence · Clinical Programs

Neuroscience Trials Australia projects

3 ClinicalTrials.gov programs sponsored by Neuroscience Trials Australia.

Neuroscience Trials Australia has 3 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. Bone marrow derived stem cells

    Neuroscience Trials Australia

    Spinal Cord Injury

    phase 2 other active

    1 trial
  2. Tenecteplase

    Neuroscience Trials Australia

    Ischemic Stroke

    phase 2 small molecule completed

    1 trial
  3. Tranexamic Acid

    Neuroscience Trials Australia

    Intracerebral Haemorrhage

    phase 2 small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does Neuroscience Trials Australia have?

3 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.